The European Medicine Agency (EMA) will organise a public meeting on 11 December 2020 to inform European citizens about the EU regulatory processes for the approval of COVID-19 vaccines and the Agency’s role in their development, evaluation, approval and safety monitoring.
The COVID-19 pandemic is an unprecedented global crisis, with devastating health, social and economic impact. Safe and effective vaccines for COVID-19 are urgently needed to respond to this crisis and reduce its effects. EMA is supporting the development of COVID-19 vaccines and has taken steps to speed up the evaluation processes for these vaccines.
The public meeting will inform citizens about EMA’s role in the pandemic and of EU regulatory procedures. It will also give the opportunity to the public and stakeholder groups to speak and share their needs, expectations and any concerns. Those interested in making an intervention during the public meeting can fill a form on the EMA site no later than 27 November 2020.
The public meeting will be broadcast live and will be open to all citizens on 11 December at 13:00 – 16:30 (CET). The broadcast link will be available on the day. There is no need to register in advance to follow the live broadcast.
The agenda of the event is already available on the EMA website.